Cargando…
Adverse effects, pharmacological interactions, and cardiovascular drugs in COVID-19 treatment
In severe coronavirus disease (COVID)-19 patients, an extraordinary systemic inflammatory response is seen. It could impact in multiple organ disorders, specially a severe myocardial injury, an acute myocarditis results in focal or global myocardial inflammation and necrosis. Those events can be pre...
Autores principales: | Chuquiure-Valenzuela, Eduardo, Chuquiure-Valenzuela, Patricia, Chuquiure-Gil, María J., Bobadilla-Chuquiure, María P., Chuquiure-Valenzuela, Javier, Chuquiure-Lardizabal, Eduardo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Permanyer Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10161861/ https://www.ncbi.nlm.nih.gov/pubmed/33459727 http://dx.doi.org/10.24875/ACM.20000234 |
Ejemplares similares
-
Explaining the increment in coronary heart disease mortality in Mexico between 2000 and 2012
por: Arroyo-Quiroz, Carmen, et al.
Publicado: (2020) -
Distrés psicológico y necesidades de información insatisfechas en pacientes con insuficiencia cardiaca y disfunción ventricular sin trastorno psiquiátrico previamente diagnosticado. Estudio transversal en un centro de referencia nacional
por: Silva-Ruz, Carlos, et al.
Publicado: (2022) -
Characteristics and 2‐year outcomes of dabigatran treatment in patients with heart failure and atrial fibrillation: GLORIA‐AF
por: Dubner, Sergio J., et al.
Publicado: (2020) -
Management of Cardiovascular Disease Patients With Confirmed or Suspected COVID-19 in Limited Resource Settings
por: Prabhakaran, Dorairaj, et al.
Publicado: (2020) -
Correction: Management of Cardiovascular Disease Patients With Confirmed or Suspected COVID-19 in Limited Resource Settings
por: Prabhakaran, Dorairaj, et al.
Publicado: (2020)